The Nobel Prize winning drug Ivermectin has been studied for its potential to treat cancer very successfully for several years now.
A 2018 publication in the American Journal of Cancer Research identified 9 molecular mechanisms of antitumor effects of ivermectin. These appear to be achievable at normal human doses.
Ivermectin has been used successfully in a small number of patients already.
Since Ivermectin is long out of patent and priced at cents per dose, the Pharma industry (and by extension the FDA) will, in my opinion, most likely prefer to continue to portray it as a horse drug.
But, then again, you may have heard the phrase “as healthy as a horse”.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835698/
https://www.tandfonline.com/doi/full/10.2147/DDDT.S237393
https://link.springer.com/article/10.1007/s00280-020-04041-z
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563063/
#IvermectinResearch
#CancerTreatment
#AntitumorEffects
#NobelPrizeDrug
#MedicalBreakthrough
#IvermectinSuccess
#CancerTherapy
#HealthInnovation
#AffordableMedicine
#PharmaIndustry
#MedicalDiscoveries
#HealthyAsAHorse
#EvidenceBasedMedicine
#ScientificResearch
#CancerTreatmentOptions
